Atopic dermatitis (AD) presents as a long-term, recurring inflammatory disorder of the skin, and its characteristic itching significantly affects patients' daily living standards. The research was ...

Perioral dermatitis is a common inflammatory skin disease presenting as tiny papules or pustules localized around the mouth, nose, or eyes. It is often confused with acne vulgaris, rosacea ...

Dermatitis. 2010;21(1):59-60. A 47-year-old female presented for evaluation of a pruritic and painful vulvar dermatitis. The dermatitis began approximately 3 years prior to presentation, shortly ...

The atopic dermatitis app will launch first in the UK, followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later in 2022. Image Phil Taylor ...

The approval comes at a critical time: approximately 6% of adolescents within this newly approved age group suffer from atopic dermatitis in the UK. In other words, one in five children.

The unusual dermatologic manifestation led to suspicion of infectious and inflammatory diseases, and the diagnosis of ulcers secondary to malignant emboli was confirmed after the development of ...

Adbry (tralokinumab-ldrm) was approved by the FDA in 2021. It is available for people 12 and older with moderate to severe atopic dermatitis. This medication targets IL-13. Ebglyss (lebrikizumab-lbkz) ...